Lack of Racial Diversity in Clinical Studies is Putting Americans In Danger
Before a drug or medical device gets FDA approval, they are (in theory, at least) required to undergo a stringent testing process known as clinical trials. Without going into the issues of lax enforcement by the FDA and bias in testing that is financed by the drug and device makers themselves, there is another serious issue with clinical trials – and that is ethnic and racial diversity. One example of this is Type 2 diabetes. For genetic reasons, African-Americans and Native Americans suffer from this disorder more frequently than do people of European ancestry. However, when it comes to...
Read More